Filter 5,800+ US stocks across valuation, growth, quality, income, and momentum metrics.
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $1273.46 | -2.5% | $1.2T | 55.5 | 94.8% | 0.5% | Healthcare | 55.1% | 49.6% | ||
| 2 | Johnson & Johnson | $263.81 | -1.4% | $635.05B | 23.9 | -38.8% | 1.9% | Healthcare | 37.1% | 6.3% | ||
| 3 | AbbVie Inc. | $285.64 | 0.3% | $504.67B | 120.5 | 68.1% | 2.3% | Healthcare | 25.1% | 10.4% | ||
| 4 | UnitedHealth Group Incorporated | $418.09 | -1.6% | $379.69B | 31.6 | -8.6% | 2.1% | Healthcare | 16% | 3.3% | ||
| 5 | Merck & Co., Inc. | $145.27 | -1.3% | $358.79B | 20.0 | -80.7% | 2.2% | Healthcare | 66.6% | 4.2% | ||
| 6 | Novartis AG | $151.12 | -3.3% | $287.24B | 21.0 | -3.4% | 2.7% | Healthcare | 14.8% | 0.8% | ||
| 7 | Thermo Fisher Scientific Inc. | $673.82 | -0.4% | $250.41B | 38.0 | 9.5% | 0.3% | Healthcare | 17.8% | 8.3% | ||
| 8 | Amgen Inc. | $439.26 | -1.8% | $237.07B | 30.9 | 31.6% | 2.2% | Healthcare | 50% | 9.2% | ||
| 9 | Gilead Sciences, Inc. | $156.04 | -0.7% | $193.73B | 23.0 | -153.2% | 2% | Healthcare | 29.2% | 5.5% | ||
| 10 | Abbott Laboratories | $103.70 | 1.2% | $180.63B | 27.9 | -61% | 2.3% | Healthcare | -17.9% | 8.1% | ||
| 11 | Novo Nordisk A/S | $39.05 | -1% | $173.41B | 11.3 | 5% | 4.5% | Healthcare | -26.6% | 5.6% | ||
| 12 | Pfizer Inc. | $30.03 | -1.3% | $171.15B | 22.1 | -59.9% | 5.7% | Healthcare | 21.7% | -0.2% | ||
| 13 | Danaher Corporation | $230.50 | 0.3% | $162.04B | 45.7 | 26% | 0.5% | Healthcare | 3.5% | 5.5% | ||
| 14 | Intuitive Surgical, Inc. | $452.29 | 1.9% | $159.78B | 57.5 | 10.2% | — | Healthcare | -18% | 20.5% | ||
| 15 | Vertex Pharmaceuticals Incorporated | $523.93 | -2.1% | $132.98B | 34.2 | 22.8% | — | Healthcare | 24% | 10.6% | ||
| 16 | AstraZeneca PLC | $171.49 | -0.6% | $132.9B | 13.1 | -22% | 3.7% | Healthcare | 1.9% | 8.6% | ||
| 17 | Bristol-Myers Squibb Company | $61.48 | -2.4% | $125.55B | 17.8 | 83.4% | 4% | Healthcare | 40.3% | 3.1% | ||
| 18 | Medtronic plc | $95.41 | -1.2% | $122.5B | 25.6 | 11.8% | 3% | Healthcare | 1.3% | 9.8% | ||
| 19 | McKesson Corporation | $1000.77 | -1.1% | $119.29B | 26.1 | 49.1% | 0.3% | Healthcare | 26.2% | 8.8% | ||
| 20 | CVS Health Corp. | $93.47 | -1.1% | $119.26B | 67.2 | 5.6% | 2.9% | Healthcare | 15.3% | 7.4% | ||
| 21 | Stryker Corporation | $307.15 | 0% | $117.75B | 36.6 | 27.8% | 1.1% | Healthcare | -19.8% | 8.5% | ||
| 22 | GSK plc | $50.75 | -0.9% | $101.68B | 13.7 | -10.9% | 3.2% | Healthcare | 11.4% | 3.2% | ||
| 23 | HCA Healthcare, Inc. | $469.03 | 0.4% | $101.55B | 16.5 | 25.5% | 0.6% | Healthcare | 6.6% | 7.3% | ||
| 24 | Sanofi | $41.60 | -0.9% | $99.89B | 11.6 | -84.5% | 5.9% | Healthcare | -16% | 21.2% | ||
| 25 | Elevance Health Inc. | $439.95 | -1.2% | $95.41B | 17.5 | -4.1% | 1.6% | Healthcare | 27.1% | 3.6% | ||
| 26 | Regeneron Pharmaceuticals, Inc. | $805.02 | -1.7% | $82.93B | 19.4 | 1.9% | 0.4% | Healthcare | 39.8% | 9.3% | ||
| 27 | Cigna Corporation | $306.95 | -2.8% | $81.2B | 13.8 | 31.9% | 2% | Healthcare | 0.6% | 7.7% | ||
| 28 | Moderna, Inc. | $200.10 | -1.2% | $79.4B | -27.6 | -6% | — | Healthcare | 662.3% | -27.2% | ||
| 29 | Boston Scientific Corporation | $45.69 | -0.7% | $67.91B | 23.6 | 46.7% | — | Healthcare | -55.4% | 13.5% | ||
| 30 | Cencora, Inc. | $331.00 | -2.2% | $64.4B | 41.6 | 38.5% | 0.7% | Healthcare | 0.7% | 5.1% | ||
| 31 | Takeda Pharmaceutical Company Limited | $20.24 | -0.6% | $64.39B | 49.7 | 32.7% | 3.3% | Healthcare | 44% | 4% | ||
| 32 | Cardinal Health, Inc. | $249.57 | -2.4% | $58.45B | 34.5 | 12.1% | 0.8% | Healthcare | 56.8% | 14.2% | ||
| 33 | Natera, Inc. | $403.95 | 0.6% | $57.85B | -265.8 | 28.8% | — | Healthcare | 107.2% | 37.8% | ||
| 34 | argenx SE | $873.71 | -0.2% | $56.27B | 44.5 | 446.7% | — | Healthcare | 7.6% | 234.9% | ||
| 35 | Becton, Dickinson and Company | $198.91 | -0.8% | $54.81B | 34.1 | -40.3% | 2.1% | Healthcare | 72.5% | -2.6% | ||
| 36 | Veeva Systems Inc. | $323.04 | 0.2% | $52.48B | 59.4 | 25.1% | — | Healthcare | 10.8% | 16.5% | ||
| 37 | Edwards Lifesciences Corporation | $89.07 | -1.1% | $51.29B | 48.7 | -75% | — | Healthcare | 16.4% | 14.6% | ||
| 38 | Humana Inc. | $422.07 | 0.3% | $50.67B | 42.9 | -19% | 0.8% | Healthcare | 44.9% | 18.3% | ||
| 39 | Agilent Technologies, Inc. | $173.07 | -0.5% | $48.88B | 37.9 | 19.2% | 0.6% | Healthcare | 17.4% | 8.6% | ||
| 40 | Teva Pharmaceutical Industries Limited | $39.41 | -2% | $46.54B | 32.8 | 475% | — | Healthcare | 107.2% | 4.1% | ||